ABBEY BRUNO: Open Payments
NPI 1669994927 · COVINGTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,320 in 102 payments from 38 companies in 2025. Trend: 2023 $2,793 · 2024 $2,590 · 2025 $2,320
Food & beverage: $2,210Education: $110
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 7 | $159 |
| Novartis Pharmaceuticals Corporation | 6 | $156 |
| AstraZeneca Pharmaceuticals LP | 7 | $152 |
| PFIZER INC. | 8 | $137 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $136 |
| Incyte Corporation | 4 | $127 |
| Janssen Biotech, Inc. | 5 | $116 |
| ABBVIE INC. | 5 | $110 |
| Genentech USA, Inc. | 5 | $101 |
| GENZYME CORPORATION | 3 | $97 |
Products named: Enhertu, FRUZAQLA, VENCLEXTA, LIBTAYO, BRAFTOVI, SARCLISA, Nubeqa, TEVIMBRA.
Industry payments across GA — which companies pay providers there.
